Adventris Pharmaceuticals
YC W23Baltimore, US · Founded 2022 · 7 employees · 2 known investors
Adventris is a biotechnology company developing cancer immunotherapy treatments.
Founders & leadership· Y Combinator alumni (W23)
Investors · 2
In the news
- Johns Hopkins researchers pitch future of science and tech at Innovation Summit | Hubhub.jhu.edu · 2025
- HBS Alumni Startup Corner: 2023 Funding Updateharbus.org · 2023